Growth Metrics

Bio-Techne (TECH) FCF Payout Ratio (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Bio-Techne 7.92 Bn 7.71 Bn 208.29 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -1.02%
Dec 31, 2025 -70.89%
Sep 30, 2025 321.84%
Jun 30, 2025 -67.29%
Mar 31, 2025 147.04%
Dec 31, 2024 -29.15%
Sep 30, 2024 5.62%
Jun 30, 2024 12.65%
Mar 31, 2024 5.91%
Dec 31, 2023 -33.41%
Sep 30, 2023 59.18%
Jun 30, 2023 -46.48%
Mar 31, 2023 50.49%
Dec 31, 2022 -20.06%
Sep 30, 2022 91.70%
Jun 30, 2022 -35.10%
Mar 31, 2022 56.53%
Dec 31, 2021 -53.05%
Sep 30, 2021 162.26%
Jun 30, 2021 -41.94%
Mar 31, 2021 21.63%
Dec 31, 2020 -28.92%
Sep 30, 2020 -49.90%
Jun 30, 2020 46.32%
Mar 31, 2020 39.93%
Dec 31, 2019 -46.14%
Sep 30, 2019 47.96%
Jun 30, 2019 -21.24%
Mar 31, 2019 20.80%
Dec 31, 2018 -15.84%
Sep 30, 2018 67.87%
Jun 30, 2018 -69.17%
Mar 31, 2018 81.16%
Dec 31, 2017 20.32%
Sep 30, 2017 18.53%
Jun 30, 2017 -54.99%
Mar 31, 2017 84.68%
Dec 31, 2016 -37.92%
Sep 30, 2016 39.90%
Jun 30, 2016 2.16%
Mar 31, 2016 -1.89%
Dec 31, 2015 -23.54%
Sep 30, 2015 17.52%
Jun 30, 2015 -14.37%
Mar 31, 2015 26.25%
Dec 31, 2014 -2.21%
Sep 30, 2014 16.28%
Jun 30, 2014 -14.15%
Mar 31, 2014 -9.73%
Dec 31, 2013 7.57%
Sep 30, 2013 -14.36%
Jun 30, 2013 8.13%
Mar 31, 2013 -13.41%
Dec 31, 2012 24.23%
Sep 30, 2012 35.65%
Jun 30, 2012 -9.46%
Mar 31, 2012 -44.75%
Dec 31, 2011 88.90%
Sep 30, 2011 0.16%
Jun 30, 2011 -4.74%
Mar 31, 2011 -9.57%
Dec 31, 2010 7.34%
Sep 30, 2010 2.71%
Jun 30, 2010 -28.77%
Mar 31, 2010 22.09%
Dec 31, 2009 7.24%